CD22 AS TARGET FOR RADIOIMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES OF B-CELL ORIGIN (NON-HODGKINS-LYMPHOMA, ACUTE LYMPHATIC-LEUKEMIA AND MACROGLOBULINEMIA)
Tm. Behr et al., CD22 AS TARGET FOR RADIOIMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCIES OF B-CELL ORIGIN (NON-HODGKINS-LYMPHOMA, ACUTE LYMPHATIC-LEUKEMIA AND MACROGLOBULINEMIA), European journal of cancer, 33, 1997, pp. 1187-1187